SCHEMBL10018151

SCHEMBL10018151

NC1=NCN(Cc2ccccc2)c2nc(-c3ccccc3)n(Cc3ccccc3)c21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.51
PDE6D O43924 1/20 0.51
ALDH2 P05091 1/20 0.51
ALDH3A1 P30838 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 3/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 2/20 0.48
RECQL P46063 1/20 0.48
RAB9A P51151 1/20 0.48
TP53 P04637 4/20 0.44
PDE5A O76074 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10018159 0.94 ALDH1A1 (0.51) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL10018158 0.77 KMT2A (0.46) ALDH1A1KDM4ELMNARAB9AMAPT
SCHEMBL10018160 0.73 KDM4E (0.42) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL563046 0.72 ALDH1A1 (0.46) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL562165 0.69 ALDH1A1 (0.49) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL18152788 0.68 ALDH1A1 (0.61) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL229828 0.68 ALDH1A1 (1.00) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL562684 0.67 ALDH1A1 (0.50) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2
SCHEMBL10018161 0.67 TLR7 (0.38) ALDH1A1SMN1; SMN2KDM4ELMNARAB9A
SCHEMBL9006294 0.66 ALDH1A1 (0.80) ALDH1A1PDE6DALDH2ALDH3A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE THOC2, TUBGCP2, TBC1D5 ALDH1A1 1329/4885PDE6D 1821/4885ALDH2 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.